Determine the necessary mass, volume, or concentration for preparing a solution.
Bimekizumab (anti-IL17A&IL-17F) (Ab182793) - ELISA
Immobilized Human CTLA-8/IL-17A-His Tag Protein at 2.0 μg/mL can bind Bimekizumab (anti-IL17A&IL-17F) (Ab182793) with the EC50 of 2.30 ng/mL.

